The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals.
about
Why don't CD8+ T cells reduce the lifespan of SIV-infected cells in vivo?Antiretroviral therapy in macrophages: implication for HIV eradication.Extracorporeal photopheresis in chronic graft-versus-host disease.HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos SantosAntitumour effects of antiretroviral therapy.In vitro and in vivo effects of HIV protease inhibitors on apoptosis.The HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation.In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers.HIV protease inhibitors impact on apoptosis.Prevention and treatment of acute GvHD.HIV protease inhibitors: recent clinical trials and recommendations on use.Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009.Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study.Indinavir impairs protein synthesis and phosphorylations of MAPKs in mouse C2C12 myocytes.Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
P2860
Q31032227-CE2AD656-F0CE-4A1E-B39C-A81E2468DF4EQ34298792-D5BC1D1C-7896-4114-8BD5-6FA5E841CABFQ34662907-1D51EBD5-0519-4C51-B4E7-13E2CB3BDEBFQ34878614-2430ADAC-0385-4CE4-BA40-966C19787039Q35934144-8F514F41-668F-4A6B-9677-D75196E81C6EQ36068283-EE493818-026A-496C-B3E8-DD0521FF94A7Q36232217-885F9CC1-8333-4601-8D26-36116AE50970Q36632220-3024551D-C871-4059-AB19-70B3644F1DFAQ37066766-CD37E7E3-BFC1-47C1-B889-B4220494006BQ37188487-63340408-1BDE-4EA0-89CC-FFBE9D35EA92Q37519715-19CC6A3A-FDD8-4AC3-B0C0-430B5C825364Q39003144-0139AD54-1C5C-4FD8-B82E-CF7C8693EAD5Q39006642-7A8B0CAA-1722-4F99-8A3F-FBA7F264B3B4Q42464012-A26EF144-6337-4CAB-8460-688D2220C4B6Q45723089-EA43168A-C16A-4EF5-86FC-EA2BEEEBAB2E
P2860
The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
The HIV protease inhibitor Ind ...... ed and uninfected individuals.
@en
type
label
The HIV protease inhibitor Ind ...... ed and uninfected individuals.
@en
prefLabel
The HIV protease inhibitor Ind ...... ed and uninfected individuals.
@en
P2093
P356
P1433
P1476
The HIV protease inhibitor Ind ...... ed and uninfected individuals.
@en
P2093
P304
P356
10.1182/BLOOD.V98.2.383
P407
P577
2001-07-01T00:00:00Z